Search
Subscribe
Latest Stories
Business
Legal
Pipeline
Research
Events
Products
Clinical Articles
Ocular Surface
Contact Lenses
Glaucoma
Retina
Pediatrics
SEE MORE »
Jobs
Optometrist Jobs
Ophthalmologist Jobs
Optician & Technician Jobs
Hiring Services for Employers
SEE ALL JOBS »
Virtual Events
Upcoming Events
Stories
Business
Legal
Pipeline
Research
Events
Products
Archives
See All Stories
Resources
Reports
Cheat Sheets
Ultimate Guides
Calculators & Tools
See All Resources
Events
Courses
Jobs
Search Eyecare Jobs
Hiring Services for Employers
Category
Pipeline
1
Organizations
Bausch + Lomb
64
Alcon, Inc.
43
Eyes On Eyecare
43
American Optometric Association
34
Harrow
28
Glaukos
26
Regeneron
22
Topcon Healthcare
22
Aldeyra Therapeutics
20
Sight Sciences
19
Tags
Clinical Trials
1
Injections
1
Thyroid Eye Disease (ted)
1
Organizations:
Acelyrin, Inc.
✕
Clear all
Pipeline
Acelyrin announces phase 2 data and phase 3 design for TED therapy
Clinical findings support lonigutamab as the first subcutaneous anti-IGF-1R to demonstrate robust efficacy in TED patients comparable to IV-administered standard of care.
